Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$914.37 8.99 (0.99%) as of 4:30 Mon 7/1


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 874.67(B)
Last Volume: 2,545,641 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 51 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-07-23 5 GD $0.00 $0 D/D 12 61,005     -
   Alvarez Ralph Director   –       •      –    2015-06-30 4 A $82.92 $9,950 D/D 120 27,737     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-06-10 4 S $82.02 $17,302,519 D/D (210,000) 129,620,804     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2015-06-04 5 GD $0.00 $0 D/D 4,500 89,356     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-06-04 4 S $77.89 $15,579,999 D/D (200,000) 129,830,804     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-06-01 4 S $79.36 $17,460,080 D/D (220,000) 130,030,804     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-05-29 4 GD $0.00 $0 D/D 685 665,329     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2015-05-29 4 S $78.08 $1,561,600 D/D (20,000) 93,856     -
   Alvarez Ralph Director   –       •      –    2015-05-29 4 A $72.94 $9,920 D/D 136 27,452     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2015-05-29 4 S $78.33 $15,666 D/D (200) 3,846     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-05-28 4 GD $0.00 $0 D/D 11,972 653,357     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-05-20 4 S $73.43 $13,951,320 D/D (190,000) 130,250,804     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-05-15 5 GA $0.00 $0 I/I 7,800 341,124     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-05-15 5 GD $0.00 $0 D/D 7,800 0     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-05-15 4 S $72.83 $14,566,400 D/D (200,000) 130,440,804     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-05-08 4 S $73.28 $14,289,795 D/D (195,000) 130,640,804     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2015-05-05 4 D $73.05 $371,240 D/D (5,082) 63,687     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2015-05-05 4 OE $56.18 $338,428 D/D 6,024 68,769     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-05-05 4 D $72.31 $3,565,461 D/D (49,308) 62,861     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2015-05-05 4 OE $52.54 $3,099,127 D/D 57,108 88,474     -
   Lilly Endowment Inc 10% Owner   –       –       •   2015-05-01 4 S $73.09 $14,617,600 D/D (200,000) 130,835,804     -
   Alvarez Ralph Director   –       •      –    2015-04-30 4 A $72.41 $9,920 D/D 137 27,316     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2015-04-28 4 D $70.89 $367,494 D/D (5,184) 39,358     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2015-04-28 4 OE $56.18 $338,428 D/D 6,024 44,542     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-04-28 4 D $70.89 $4,416,872 D/D (62,306) 670,110     -
  1436 Records found
  Previous  50  51  52  53  54  55  56  57  58   
  Page 51 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us